PMC/PubMed Indexed Articles
Indexed In
- Academic Journals Database
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Scimago
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- MIAR
- University Grants Commission
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Rajesh K. Sharma
Rajesh K. Sharma
Division of Medical Oncology, James Graham Brown Cancer Center
USA
Biography
Dr. Sharma is currently an Assistant Professor in Department of Medicine at University of Louisville,Louisville, Kentucky, USA.He completed his Ph.D. in the area of infectious immunology at Banaras Hindu University in India. Dr. Sharma then moved to USA to pursue his postdoctoral studies in the area of therapeutic cancer vaccines at the Institute for Cellular Therapeutics, Department of Microbiology & Immunology at University of Louisville. Dr. Sharma serves as reviewer for various journals. His research interests are in the area of cancer vaccines, cancer immunotherapies, particularly development of combinatorial therapeutic approaches such as chemo-immunotherapy, and defining biomarkers for early detection of various cancer types. Dr. Sharma is also involved in understanding the role of chemokine and its receptors in cancer-immune interplay and if these chemokine networks could be exploited to enhance the therapeutic efficacy of immunotherapies such as cancer vaccines.
Research Interest
His research interests are in the area of cancer vaccines, cancer immunotherapies, particularly development of combinatorial therapeutic approaches such as chemo-immunotherapy, and defining biomarkers for early detection of various cancer types